Authors:
HORNICK JL
SHARIFI J
KHAWLI LA
HU PS
BIELA BH
MIZOKAMI MM
YUN A
TAYLOR CR
EPSTEIN AL
Citation: Jl. Hornick et al., A NEW CHEMICALLY-MODIFIED CHIMERIC TNT-3 MONOCLONAL-ANTIBODY DIRECTEDAGAINST DNA FOR THE RADIOIMMUNOTHERAPY OF SOLID TUMORS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 255-268
Citation: J. Sharifi et al., OPTIMIZING PHARMACOKINETIC PERFORMANCE OF CHTNT MONOCLONAL-ANTIBODIESUSING CHEMICAL MODIFICATION, Journal of investigative medicine, 46(1), 1998, pp. 125-125
Authors:
KHAWLI LA
HORNICK JL
SHARIFI J
EPSTEIN AL
Citation: La. Khawli et al., IMPROVING THE CHEMOTHERAPEUTIC INDEX OF IUDR USING A VASOACTIVE IMMUNOCONJUGATE, Radiochimica Acta, 79(2), 1997, pp. 83-86
Citation: J. Sharifi, PRECEDENTS CONSTRUING STATUTES ADMINISTERED BY FEDERAL-AGENCIES AFTERTHE CHEVRON DECISION - WHAT GIVES, The University of Chicago law review, 60(1), 1993, pp. 223-252